Key result
Dedicated cardiopsychiatry clinic uncovers new cardiovascular risks in ~57% of patients with severe mental illness.
Why the study?
Individuals with severe mental illness face twice the risk of cardiovascular disease compared to the general population, yet disparities in cardiovascular care access persist.
Does a dedicated cardiopsychiatry clinic improve the identification of cardiovascular risk and initiation of treatment in patients with severe mental illness?
Observational (n=23)
No
Does a dedicated cardiopsychiatry clinic improve the identification of cardiovascular risk and initiation of treatment in patients with severe mental illness?
Implementation of a dedicated cardiopsychiatry clinic successfully identified new cardiovascular risks in 57% of patients with severe mental illness, facilitating the initiation of primary prevention therapies.
Answers are grounded in this paper and cite their sources.
Clinic feasible for SMI cardiovascular screening; leaves open whether integrated care improves outcomes.
INTRODUCTION: Individuals with severe mental illness (SMI), including schizophrenia, schizoaffective disorder, and bipolar disorder, face twice the risk of cardiovascular disease compared with the general population. However, disparities in cardiovascular care access persist. We established a cardiopsychiatry clinic to assess cardiovascular risk and initiate evidence-based treatment in this population. METHODS: From November 2022 to July 2023, patients with SMI but no known cardiovascular disease were referred from outpatient psychiatry clinics to a tertiary care hospital in Canada. Cardiovascular risk factors were recorded, and the 10-year Framingham Risk Score was calculated. Treatment was initiated based on clinical guidelines. RESULTS: Among 23 participants (mean age 52.6 ± 10.8 years; 30% female), schizophrenia was the most common SMI (65%). The mean Framingham Risk Score was 13.8% ± 8.1. Smoking (61%) and obesity (74%) were the most prevalent risk factors. More than half (57%) had newly identified cardiovascular risks, leading to pharmacological treatment initiation for metabolic syndrome/dyslipidemia (N = 7), hypertension (N = 7), and diabetes (N = 2). CONCLUSIONS: The cardiopsychiatry clinic is a pilot project that highlights the need for integrated cardiovascular screening and treatment for individuals with SMI. Larger studies are required to address persistent gaps in cardiovascular care for this high-risk population.
No takes yet. Share an insight, caveat, or question.
Colli et al. (2025) conducted an observational in Severe mental illness (n=23). Cardiopsychiatry clinic assessment was evaluated on Newly identified cardiovascular risks. Assessment in a dedicated cardiopsychiatry clinic identified new cardiovascular risks in 57% of patients with severe mental illness, leading to initiation of pharmacological treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: